"Iowa's really becoming a hotbed for basketball, and that's really exciting to see," said a Cyclone fan who was excited to ...

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

China is now a better partner for the European Union in facing global challenges than the United States with Donald Trump in ...

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

With a slew of tech announcements dominating the headlines recently, it’s been easy to overlook some equally important ...